tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Dermatitis D003872 30 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Pharyngitis D010612 2 associated lipids
Shock D012769 11 associated lipids
Erythema D004890 22 associated lipids
Dermatomycoses D003881 17 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Amenorrhea D000568 4 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Shock, Septic D012772 11 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Cough D003371 19 associated lipids
Paraproteinemias D010265 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Ovarian Cysts D010048 4 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Renal D006977 9 associated lipids
Metaplasia D008679 7 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Tachycardia D013610 7 associated lipids
Cicatrix D002921 9 associated lipids
Neutropenia D009503 15 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Urticaria D014581 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Thrombophlebitis D013924 6 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Garcia-Criado FJ et al. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. 1997 Transplantation pmid:9293871
Suzuki H et al. Induction of transplantation tolerance in adult rats by vascularized spleen transplantation. 1997 Transplantation pmid:9293881
Alvaro D et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. 1997 J. Clin. Invest. pmid:9294100
Ruzicka T et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. 1997 N. Engl. J. Med. pmid:9295241
Alevizopoulos A et al. Regulation of the transforming growth factor beta-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV. 1997 J. Biol. Chem. pmid:9295299
Lal SM et al. De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case. 1997 Int J Artif Organs pmid:9298410
Milićević NM and Milićević Z Stereological study of splenic tissue compartments in FK506-treated rats. 1997 Histol. Histopathol. pmid:9302561
Sperr WR et al. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. 1997 Int. Arch. Allergy Immunol. pmid:9303333
Izuishi K et al. Effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems in rat liver microsomes. 1997 Int. J. Biochem. Cell Biol. pmid:9304807
Jonas S et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. 1997 Cancer pmid:9305716
Tze WJ et al. Prolongation of pig islet xenograft survival in rats immunosuppressed with FK506. 1997 Diabetes Res. Clin. Pract. pmid:9306035
Tanaka H et al. [Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. 1997 Yakugaku Zasshi pmid:9306728
Kamada H et al. Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats. 1997 Jpn. J. Pharmacol. pmid:9307327
Ito A et al. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning. 1997 Transplantation pmid:9311715
Atkison PR et al. Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus-related cardiac toxicity in a pediatric transplant recipient. 1997 Transplantation pmid:9311719
Graef IA et al. Proximity and orientation underlie signaling by the non-receptor tyrosine kinase ZAP70. 1997 EMBO J. pmid:9312021
Wong BR et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. 1997 J. Biol. Chem. pmid:9312132
Kageyama M et al. FK506-binding proteins regulate smooth muscle contractility by altering neurotransmitter release. 1997 Eur. J. Pharmacol. pmid:9314039
Reynolds KA et al. Biosynthesis of the shikimate-derived starter unit of the immunosuppressant ascomycin: stereochemistry of the 1,4-conjugate elimination. 1997 J. Antibiot. pmid:9315087
Alarcón CM and Heitman J FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae. 1997 Mol. Cell. Biol. pmid:9315655
Goodyear N et al. The 37 kDa immunophilin has uracil DNA glycosylase but not rotamase activity. 1997 Clin. Biochem. pmid:9316745
Rudi J et al. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. 1997 Am. J. Gastroenterol. pmid:9317070
Kesten S et al. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. 1997 J. Heart Lung Transplant. pmid:9322139
Ko WJ et al. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. 1997 J. Heart Lung Transplant. pmid:9322151
Arbustini E et al. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study. 1997 J. Heart Lung Transplant. pmid:9322152
Denecker G et al. Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. 1997 Cytokine pmid:9325011
Fujita T et al. Prolonged survival of rat skin allograft by treatment with FK506 ointment. 1997 Transplantation pmid:9326422
Pratschke J et al. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. 1997 Transplantation pmid:9326428
McGhee B et al. Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. 1997 Transplantation pmid:9326429
Ilan Y et al. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. 1997 Hepatology pmid:9328318
Hara K et al. Implantation of xenogeneic transgenic neural plate tissues into parkinsonian rat brain. 1997 Sep-Oct Cell Transplant pmid:9331504
Nagai H et al. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. 1997 J. Pharmacol. Exp. Ther. pmid:9336339
Vella JP and Sayegh MH Maintenance pharmacological immunosuppressive strategies in renal transplantation. 1997 Postgrad Med J pmid:9338020
Harihara Y and Makuuchi M [Partial liver transplantation]. 1997 Nippon Naika Gakkai Zasshi pmid:9340350
Wallemacq PE et al. IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. 1997 Clin. Chem. pmid:9342026
Gold BG et al. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. 1997 Exp. Neurol. pmid:9344552
Klintmalm GB and Gonwa TA Nephrotoxicity associated with cyclosporine and FK506. 1995 Liver Transpl Surg pmid:9346596
Wong PY et al. FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. 1995 Liver Transpl Surg pmid:9346613
Cameron AM et al. FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. 1997 J. Biol. Chem. pmid:9346894
Hosoi R et al. Isoform-specific up-regulation by ouabain of Na+,K+-ATPase in cultured rat astrocytes. 1997 J. Neurochem. pmid:9349566
Krüger M et al. Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. 1997 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9349628
Prokisch H et al. Impairment of calcineurin function in Neurospora crassa reveals its essential role in hyphal growth, morphology and maintenance of the apical Ca2+ gradient. 1997 Mol. Gen. Genet. pmid:9349701
Saitoh O et al. Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29). 1997 J. Gastroenterol. pmid:9349985
Lang P and Baron C Molecular mechanisms of immunosuppressive chemical agents recently introduced in clinical transplantation protocols. 1997 Nephrol. Dial. Transplant. pmid:9351062
Waer M New immunosuppressive agents for organ transplantation. 1997 Acta Clin Belg pmid:9351290
Sheiner PA et al. Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. 1997 Transplantation pmid:9355846
Karlsson H and Nässberger L FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. 1997 Transplantation pmid:9355847
Ishida H et al. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. 1997 Toxicology pmid:9355935
Wang JH and Kelly PT Attenuation of paired-pulse facilitation associated with synaptic potentiation mediated by postsynaptic mechanisms. 1997 J. Neurophysiol. pmid:9356420
Firdaous I et al. Excretion of tacrolimus glucuronides in human bile. 1997 Jul-Sep Eur J Drug Metab Pharmacokinet pmid:9358202